HIV-1の広範囲中和抗体の誘導におけるB細胞系統の協力
Feng Gao1, Mattia Bonsignori1, Hua-Xin Liao1
1Duke University Human Vaccine Institute, Departments of Medicine, Surgery, Pediatrics and Immunology, Duke University School of Medicine, Durham NC 27710, USA; The Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery at Duke University, Durham NC 27710, USA.
Cell
|July 29, 2014
まとめ
ワクチンの戦略は,HIV-1を広く中和する抗体 (bnAbs) を誘導することを目的としています. この研究では,2つのB細胞系が協力して,感染した個体内でこれらの重要なbnAbsを開発し,免疫遺伝子の設計に関する洞察を提供することを発見しました.
科学分野:
- 免疫学 免疫学とは
- ウイルス学 ウイルス学 ウイルス学
- ワクチン開発 ワクチン開発
背景:
- ワクチンを介してHIV-1を広く中和する抗体 (bnAbs) を誘導することは,重要な研究優先事項です.
- 感染した個体におけるbnAbsの自然発達の理解は,効果的なワクチンの免疫遺伝子設計に情報を与えます.
研究 の 目的:
- 自然にHIV-1 bnAbs.を生成する個体におけるB細胞反応のダイナミクスを調査する.
- bnAbの成熟とB細胞系統間の協力のメカニズムを特定する.
主な方法:
- HIV-1 bnAbを生成する個体におけるB細胞応答の分析.
- HIV-1封筒 (ループD) を標的とする特定の抗体系統の分離.
- B細胞抗原駆動を評価するためにウイルスの脱出変異体の選択と特徴付け.
主要な成果:
- bnAbの開発を推進する2つの異なるB細胞系統の間の協力が特定されました.
- bnAb系統封筒結合の強化と脱出変異体の中和が観察されました.
- ウイルスの脱出変異に関連したB細胞抗原駆動の増加が実証されました.
結論:
- 2つのB細胞系が協力してHIV-1 bnAbs.の発症を誘発することができる.
- ワクチンの免疫原体は,効果的な抗体成熟のためにヘルパー細胞とbnAb B細胞の両方の系統を巻き込む必要があるかもしれません.
- この協力メカニズムは,bnAbs.を誘発するワクチンを設計するためのモデルを提供します.
関連する概念動画
01:24B Cell Activation and Differentiation
14.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K
01:29Immune Response Against Viral Pathogens
2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
01:23Cells of the Adaptive Immune Response
6.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.8K
01:22T Cell Activation and Clonal Selection
13.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K
01:31Hybridoma Technology
13.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.1K
01:36Humoral Immune Responses
65.8K
Overview
65.8K